ENPP2 and B-cell chronic lymphocytic leukemia: Treatment of Chronic Lymphocytic Lymphoma (CLL) cells with pyrimethamine was shown to decrease expression of STAT3 signature genes (AIM2, ATXN1, ENPP2, GAB1, and ID3) that previously exhibited higher expression in CLL cells compare to healthy B lymphocytes [186].